SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $864,000 | -69.6% | 15,200 | -59.9% | 0.00% | -88.9% |
| Q1 2021 | $2,838,000 | -74.2% | 37,919 | -70.2% | 0.01% | -74.3% |
| Q4 2020 | $11,004,000 | +39.2% | 127,195 | -1.7% | 0.04% | +20.7% |
| Q3 2020 | $7,908,000 | -57.4% | 129,377 | -71.0% | 0.03% | -21.6% |
| Q2 2020 | $18,568,000 | +627.0% | 446,544 | +402.3% | 0.04% | +516.7% |
| Q1 2020 | $2,554,000 | -62.6% | 88,902 | -6.0% | 0.01% | -57.1% |
| Q4 2019 | $6,826,000 | -47.3% | 94,554 | +2.3% | 0.01% | -46.2% |
| Q3 2019 | $12,962,000 | -23.5% | 92,394 | -0.2% | 0.03% | -21.2% |
| Q2 2019 | $16,946,000 | +135.4% | 92,558 | +104.5% | 0.03% | +17.9% |
| Q1 2019 | $7,200,000 | +66.1% | 45,270 | 0.0% | 0.03% | +47.4% |
| Q4 2018 | $4,336,000 | -55.9% | 45,270 | -34.9% | 0.02% | -47.2% |
| Q3 2018 | $9,826,000 | -9.9% | 69,570 | -0.1% | 0.04% | -14.3% |
| Q2 2018 | $10,905,000 | +7.5% | 69,670 | +10.6% | 0.04% | +5.0% |
| Q1 2018 | $10,147,000 | +36.5% | 62,994 | +39.6% | 0.04% | +37.9% |
| Q4 2017 | $7,432,000 | +156.7% | 45,120 | -2.9% | 0.03% | +141.7% |
| Q3 2017 | $2,895,000 | -20.6% | 46,464 | +1.5% | 0.01% | -29.4% |
| Q2 2017 | $3,647,000 | +8.0% | 45,788 | -3.6% | 0.02% | +13.3% |
| Q1 2017 | $3,376,000 | +34.9% | 47,509 | -3.0% | 0.02% | +25.0% |
| Q4 2016 | $2,502,000 | +13.0% | 49,002 | +1.9% | 0.01% | +20.0% |
| Q3 2016 | $2,214,000 | +53.0% | 48,075 | +0.1% | 0.01% | +66.7% |
| Q2 2016 | $1,447,000 | – | 48,031 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |